(ETON) – StreetInsider.com Reports
-
Eton Pharmaceuticals Inc. (ETON) Enters Share and Warrant Sale Agreements
-
Eton Pharmaceuticals (ETON) Acquires PKU GOLIKE for Phenylketonuria
-
Eton Pharmaceuticals Inc. (ETON) Misses Q4 EPS by 5c
-
Eton Pharmaceuticals Inc. (ETON) awarded U.S. patent for proprietary formulation of oral liquid hydrocortisone
-
Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 8c
-
Eton Pharmaceuticals (ETON) Acquires FDA-Approved Ultra-Rare Disease Product Nitisinone
-
Eton Pharmaceuticals Inc. (ETON) Tops Q2 EPS by 27c, beats revenue
-
Eton Pharmaceuticals (ETON) PT Lowered to $9 at H.C. Wainwright
-
Eton Pharmaceuticals (ETON) Receives FDA CRL for Dehydrated Alcohol Injection
-
Eton Pharmaceuticals Inc. (ETON) Tops Q1 EPS by 22c
-
Eton Pharmaceuticals (ETON) Announces Commercial Availability of Betaine Anhydrous for Oral Solution
-
Eton Pharmaceuticals Inc. (ETON) Tops Q4 EPS by 5c
-
Eton Pharmaceuticals Inc. (ETON) acquires rare disease product candidate ET-600 from Tulex
-
Eton Pharmaceuticals Inc. (ETON) Announces FDA Acceptance of NDA Response for Dehydrated Alcohol Injection
-
Eton Pharmaceuticals Inc. (ETON) submitted NDA response for its dehydrated alcohol injection product candidate to FDA
-
Eton Pharmaceuticals Inc. (ETON) Tops Q3 EPS by 6c
-
Eton Pharmaceuticals (ETON) PT Raised to $10 at H.C. Wainwright
-
Eton Pharmaceuticals Inc. (ETON) Announces Acquisition of FDA-Approved Rare Disease Product, Betaine Anhydrous for Oral Solution
-
Eton Pharmaceuticals Inc. (ETON) Misses Q2 EPS by 14c
-
Eton Pharmaceuticals (ETON) PT Lowered to $9 at H.C. Wainwright
-
Eton Pharmaceuticals Inc. (ETON) Announces FDA Approval of ZONISADE
-
Eton Pharmaceuticals Inc. (ETON) Halted, News Pending
-
Dr. Reddys Labs (RDY) Acquires Injectable Product Portfolio from Eton Pharma (ETON)
-
Eton Pharmaceuticals (ETON) Announces Sale of Hospital Products to Dr. Reddy’s (RDY) for Up to $50M
-
Eton Pharmaceuticals Inc. (ETON) Halted, News Pending
-
Pre-Open Stock Movers 04/12: (BDSX) (AGLE) (CRWD) Higher; (HOTH) (MYOV) (WULF) Lower (more...)
-
After-Hours Stock Movers 04/11: (BDSX) (AGLE) (VERU) Higher; (HOTH) (WULF) (ETON) Lower (more...)
-
Eton Pharmaceuticals Inc. (ETON) Appoints James Gruber as CFO
-
Pre-Open Stock Movers 04/11: (VERU) (SAIL) (AFMD) Higher; (NIO) (TSLA) (NVDA) Lower (more...)
-
Eton Pharmaceuticals (ETON) Announces FDA Approval of Cysteine Hydrochloride Injection
-
Eton Pharmaceuticals (ETON) PT Lowered to $11 at H.C. Wainwright
-
Eton Pharmaceuticals Inc. (ETON) Reports Q4 Earnings
-
Eton Pharmaceuticals Inc. (ETON) and XGen Pharmaceuticals DJB Announce Commercial Launch of Rezipres
-
Eton Pharmaceuticals (ETON) and ANI Pharmaceuticals (ANIP) Announce Commercial Availability of Carglumic Acid Tablets
-
Eton Pharmaceuticals (ETON) Announces Co-Promotion Agreement with Tolmar Pharmaceuticals for ALKINDI SPRINKLE
-
Eton Pharmaceuticals Inc. (ETON) and Azurity Announce FDA Approval of EPRONTIA
-
Eton Pharmaceuticals Inc. (ETON) Climbs 25% After Announcing Acquisition of Approved Orphan Drug Product Carglumic Acid
-
Eton Pharmaceuticals Inc. (ETON) Announces Acquisition of Approved Orphan Drug Product Carglumic Acid
-
B.Riley Resumes Eton Pharmaceuticals (ETON) at Buy
-
Eton Pharmaceuticals (ETON) PT Lowered to $10 at B.Riley
-
Eton Pharma (ETON) Acquires U.S. and Canadian Rights to ZENEO Hydrocortisone Autoinjector
-
Eton Pharmaceuticals Inc. (ETON) to Resume Trading at 11:10 a.m.
-
Eton Pharmaceuticals (ETON) Announces FDA Approval of Rezipres
-
Eton Pharmaceuticals Inc. (ETON) Halted, News Pending
-
Eton Pharmaceuticals (ETON) PT Lowered to $11 at B.Riley
-
Eton Pharmaceuticals (ETON) PT Lowered to $11 at B.Riley on CRL
-
Eton Pharmaceuticals Inc. (ETON) Receives CRL from U.S. FDA for Dehydrated Alcohol Injection
-
Eton Pharmaceuticals Inc. (ETON) Halted, News Pending
-
Eton Pharmaceuticals Inc. (ETON) Reports Q1 EPS of $0.19
-
Eton Pharmaceuticals (ETON) Announces Appointment of Jenn Adams to its Board of Directors
Back to ETON Stock Lookup